Journal article
Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
Journal of the American Society of Nephrology, Vol.26(5), pp.1150-1160
05/2015
DOI: 10.1681/ASN.2014040325
PMCID: PMC4413766
PMID: 25475745
Abstract
Cardiac hypertrophy occurs in up to 95% of patients with CKD and increases their risk for cardiovascular death. In the kidney, full-length membranous Klotho forms the coreceptor for fibroblast growth factor 23 (FGF23) to regulate phosphate metabolism. The prevailing view is that the decreased level of Klotho in CKD causes cardiomyopathy through increases in serum FGF23 and/or phosphate levels. However, we reported recently that soluble Klotho protects against cardiac hypertrophy by inhibiting abnormal calcium signaling in the heart. Here, we tested whether this protective effect requires changes in FGF23 and/or phosphate levels. Heterozygous Klotho-deficient CKD mice exhibited aggravated cardiac hypertrophy compared with wild-type CKD mice. Cardiac magnetic resonance imaging studies revealed that Klotho-deficient CKD hearts had worse functional impairment than wild-type CKD hearts. Normalization of serum phosphate and FGF23 levels by dietary phosphate restriction did not abrogate the aggravated cardiac hypertrophy observed in Klotho-deficient CKD mice. Circulating levels of the cleaved soluble ectodomain of Klotho were lower in wild-type CKD mice than in control mice and even lower in Klotho-deficient CKD mice. Intravenous delivery of a transgene encoding soluble Klotho ameliorated cardiac hypertrophy in Klotho-deficient CKD mice. These results suggest that the decreased level of circulating soluble Klotho in CKD is an important cause of uremic cardiomyopathy independent of FGF23 and phosphate, opening new avenues for treatment of this disease.
Details
- Title: Subtitle
- Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
- Creators
- Jian Xie - Division of Nephrology, Department of MedicineJoonho Yoon - Division of Nephrology, Department of MedicineSung-Wan An - Division of Nephrology, Department of MedicineMakoto Kuro-o - Department of Pathology, and Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas; and Center for Molecular Medicine, Jichi Medical University, Tochigi, JapanChou-Long Huang - Division of Nephrology, Department of Medicine, Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas; and Chou-long.huang@utsouthwestern.edu
- Resource Type
- Journal article
- Publication Details
- Journal of the American Society of Nephrology, Vol.26(5), pp.1150-1160
- DOI
- 10.1681/ASN.2014040325
- PMID
- 25475745
- PMCID
- PMC4413766
- NLM abbreviation
- J Am Soc Nephrol
- ISSN
- 1046-6673
- eISSN
- 1533-3450
- Grant note
- P30 DK079328 / NIDDK NIH HHS R01 DK085726 / NIDDK NIH HHS R01-DK100605 / NIDDK NIH HHS R01 DK100605 / NIDDK NIH HHS R01-DK85726 / NIDDK NIH HHS P30-DK79328 / NIDDK NIH HHS
- Language
- English
- Date published
- 05/2015
- Academic Unit
- Nephrology; Internal Medicine
- Record Identifier
- 9984094554402771
Metrics
17 Record Views